Chronic use of intracerebral dialysis for the in vivo measurement of 3,4-dihydroxyphenylethylamine and its metabolite 3,4-dihydroxyphenylacetic acid.
about
Sustained exposure to the widely used herbicide atrazine: altered function and loss of neurons in brain monoamine systems.A review of the effects of FSCV and microdialysis measurements on dopamine release in the surrounding tissueIn vivo microdialysis sampling: theory and applications.Multi-site binding of fenoprofen to human serum albumin studied by a combined technique of microdialysis with high performance liquid chromatography.Multiple system degeneration with glutamate dehydrogenase deficiency: pathology and biochemistryPhasic acetylcholine release and the volume transmission hypothesis: time to move on.Dopamine mechanisms of cocaine addiction.Daily monitoring of dopamine efflux reveals a short-lasting occlusion of the dopamine agonist properties of d-amphetamine by dopamine transporter blockers GBR 12909 and methylphenidate.Evidence for Tonic Control by the GABAA Receptor of Extracellular D-Serine Concentrations in the Medial Prefrontal Cortex of Rodents.Motor activity induces release of serotonin in the dorsal horn of the rat lumbar spinal cord.Serotonin release variations during recovery of motor function after a spinal cord injury in rats.Effects of oral exposure to mining waste on in vivo dopamine release from rat striatum.Effect of quinine on autoreceptor-regulated dopamine release in the rat striatum.In vivo release of dopamine from rat striatum, substantia nigra and prefrontal cortex: differential modulation by baclofen.Microdialysis in the rat striatum: effects of 24 h dexamethasone retrodialysis on evoked dopamine release and penetration injury.Modulation of extracellular d-serine content by calcium permeable AMPA receptors in rat medial prefrontal cortex as revealed by in vivo microdialysis.
P2860
Q24813197-9914E668-6A46-427B-9113-92627EB86432Q28394513-0CCEEE63-C61F-4F89-BB63-229594EB743CQ30745107-F92182D1-7E6D-4A04-A205-11AF86645D0DQ32117235-FADD570C-1B00-4778-A7FB-A3830D1E9C02Q36942944-F80E9089-523F-4396-B79B-2F0AA6F27AEFQ37450800-B7BD8FB0-DC92-4CAA-A64D-B2201F4C5CC9Q40575529-5A6258B3-F810-4A93-B4F3-269C91AC0AE8Q40790106-7A31EE18-55DF-4E99-857B-EDCB3716ECA0Q41204076-AC8B3D84-00BA-4A6F-92C1-3FA8717686C5Q41312363-210F9D0F-B12B-4FD3-9F96-C8F43507FB44Q41810039-CBD6792E-F9F0-47CE-B960-5CFB8D8C8E20Q41964768-033BF4AF-E53D-49BA-8E08-908BA4C28D92Q42005612-AFDCF2AA-9DB2-47A2-A744-370549ACF45EQ42026628-E0EE224D-7D00-4799-8BBE-A45ACF0A4390Q43117098-621B3184-A97E-4BF6-BD8D-BB89FEEBB740Q46471715-5CCA6711-91F6-4A67-A100-548EFF2137B3
P2860
Chronic use of intracerebral dialysis for the in vivo measurement of 3,4-dihydroxyphenylethylamine and its metabolite 3,4-dihydroxyphenylacetic acid.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh-hant
name
Chronic use of intracerebral d ...... ,4-dihydroxyphenylacetic acid.
@en
Chronic use of intracerebral d ...... ,4-dihydroxyphenylacetic acid.
@nl
type
label
Chronic use of intracerebral d ...... ,4-dihydroxyphenylacetic acid.
@en
Chronic use of intracerebral d ...... ,4-dihydroxyphenylacetic acid.
@nl
prefLabel
Chronic use of intracerebral d ...... ,4-dihydroxyphenylacetic acid.
@en
Chronic use of intracerebral d ...... ,4-dihydroxyphenylacetic acid.
@nl
P2860
P1476
Chronic use of intracerebral d ...... ,4-dihydroxyphenylacetic acid.
@en
P2093
Westerink BH
P2860
P304
P356
10.1111/J.1471-4159.1986.TB12942.X
P407
P577
1986-01-01T00:00:00Z